AR017250A1 - Compuestos derivados cis-substituidos de fluorometilpirrolidina, sus sales o hidratos, utiles como agentes antibacterianos, medicamento, agenteantibacteriano, y compuestos intermediarios. - Google Patents
Compuestos derivados cis-substituidos de fluorometilpirrolidina, sus sales o hidratos, utiles como agentes antibacterianos, medicamento, agenteantibacteriano, y compuestos intermediarios.Info
- Publication number
- AR017250A1 AR017250A1 ARP980103028A ARP980103028A AR017250A1 AR 017250 A1 AR017250 A1 AR 017250A1 AR P980103028 A ARP980103028 A AR P980103028A AR P980103028 A ARP980103028 A AR P980103028A AR 017250 A1 AR017250 A1 AR 017250A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- hydrogen atom
- salts
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos representados por la formula (I), sus sales o hidratos, donde R1 representa un átomo de hidrogeno o un grupo alquilo C1-6, donde elgrupo alquilo puede tener uno o más sustituyentes seleccionados del grupo formado por un grupo hidroxilo, unátomo de halogeno, un grupo alquiltio C1-6 y ungrupo alcoxilo C1-6; R2 representa un grupo halogenometoxilo o un grupo alcoxilo; R3 representa un grupo alquilo, un grupo alquenilo, un grupo halogenoalquilo, un grupo alquilo cíclico, un grupo heteroarilo, un grupo alcoxilo o un grupo alquilamino, y R4 representa un átomo de hidrogeno, un grupo fenilo,un grupo acetoximetilo, un grupo pivaloiloximetilo, un grupo etoxicarbonilo, un grupo colina, un grupo dimetilaminoetilo, un grupo 5-indanilo, un grupoftalidinilo, un grupo 5-alquilo-2-oxo-1,3-dioxol-4-ilmetilo, un grupo-3-acetoxi-2-oxobutilo, un grupo alquilo, un grupo alcoximetilo o un grupofenilalquilo. Estos sustituyentes pueden tener además sustituyentes adicionales. Los compuestos se incluyen en medicamentos y agentes antibacterianoscomo principio activo. Para la preparacion de dichos compuestos se usan intermediarios de formula (II), donde R11 y R12 son cada uno, independientementeun átomo de hidrogeno, un grupo alquilo C1-6 o un grupo protector del grupo amino y Q representa un grupo protector del grupo amino o un átomo dehidrogeno.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16643897 | 1997-06-24 | ||
| JP5470098 | 1998-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017250A1 true AR017250A1 (es) | 2001-09-05 |
Family
ID=26395502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103028A AR017250A1 (es) | 1997-06-24 | 1998-06-24 | Compuestos derivados cis-substituidos de fluorometilpirrolidina, sus sales o hidratos, utiles como agentes antibacterianos, medicamento, agenteantibacteriano, y compuestos intermediarios. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6656952B2 (es) |
| EP (1) | EP0995744B1 (es) |
| KR (1) | KR20010014209A (es) |
| CN (1) | CN1268132A (es) |
| AR (1) | AR017250A1 (es) |
| AU (1) | AU8038798A (es) |
| DE (1) | DE69811367T2 (es) |
| MY (1) | MY132897A (es) |
| NO (1) | NO996390L (es) |
| TW (1) | TW382625B (es) |
| WO (1) | WO1998058923A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1161956A4 (en) | 1999-03-17 | 2005-03-16 | Daiichi Seiyaku Co | DRUG COMPOSITIONS |
| CN1269817C (zh) | 2000-11-20 | 2006-08-16 | 第一制药株式会社 | 脱卤代化合物 |
| US6878713B2 (en) | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6964966B2 (en) | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| ATE366734T1 (de) | 2003-09-04 | 2007-08-15 | Wockhardt Ltd | Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat |
| JPWO2005073238A1 (ja) * | 2004-02-02 | 2007-09-13 | 第一製薬株式会社 | ピリドベンズオキサジン誘導体 |
| US7977327B2 (en) * | 2004-05-13 | 2011-07-12 | Daiichi Sankyo Company, Limited | Substituted pyrrolidine derivative |
| TW200640899A (en) * | 2005-01-21 | 2006-12-01 | Daiichi Seiyaku Co | Fluoroalkylpyrrolidine derivative |
| US7563805B2 (en) | 2005-05-19 | 2009-07-21 | Daiichi Pharmaceutical Co., Ltd. | Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| EP1999125A2 (en) * | 2006-03-28 | 2008-12-10 | The Procter and Gamble Company | A coupling process for preparing quinolone intermediates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0696572B2 (ja) * | 1985-07-17 | 1994-11-30 | 大日本製薬株式会社 | ピリドンカルボン酸誘導体、そのエステルおよびその塩 |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
| JPS63152318A (ja) | 1986-08-07 | 1988-06-24 | Dainippon Pharmaceut Co Ltd | 抗マイコプラズマ剤 |
| JPH07108898B2 (ja) * | 1986-08-20 | 1995-11-22 | 大日本製薬株式会社 | ３−アミノピロリジン誘導体およびその塩の製造法 |
| JPH03188074A (ja) * | 1989-03-31 | 1991-08-16 | Wakunaga Pharmaceut Co Ltd | 新規キノロン誘導体及びこれを含有する抗菌剤 |
| JP3188074B2 (ja) | 1993-10-26 | 2001-07-16 | 三菱重工業株式会社 | 蒸気タービンの翼溝部防食方法 |
| JP3745433B2 (ja) | 1995-02-02 | 2006-02-15 | 第一製薬株式会社 | 複素環式化合物 |
| JP3771620B2 (ja) * | 1995-02-07 | 2006-04-26 | 第一製薬株式会社 | ヘテロ環式スピロ誘導体 |
| JP3833738B2 (ja) * | 1995-11-15 | 2006-10-18 | 第一製薬株式会社 | 置換アミノメチルピロリジン誘導体 |
-
1998
- 1998-06-23 MY MYPI98002846A patent/MY132897A/en unknown
- 1998-06-23 EP EP98928627A patent/EP0995744B1/en not_active Expired - Lifetime
- 1998-06-23 AU AU80387/98A patent/AU8038798A/en not_active Abandoned
- 1998-06-23 WO PCT/JP1998/002787 patent/WO1998058923A1/ja not_active Application Discontinuation
- 1998-06-23 DE DE69811367T patent/DE69811367T2/de not_active Expired - Fee Related
- 1998-06-23 CN CN98808422A patent/CN1268132A/zh active Pending
- 1998-06-23 US US09/446,696 patent/US6656952B2/en not_active Expired - Fee Related
- 1998-06-23 KR KR1019997012290A patent/KR20010014209A/ko not_active Application Discontinuation
- 1998-06-24 TW TW087110150A patent/TW382625B/zh not_active IP Right Cessation
- 1998-06-24 AR ARP980103028A patent/AR017250A1/es unknown
-
1999
- 1999-12-22 NO NO996390A patent/NO996390L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20020072608A1 (en) | 2002-06-13 |
| DE69811367D1 (de) | 2003-03-20 |
| CN1268132A (zh) | 2000-09-27 |
| NO996390L (no) | 2000-02-24 |
| NO996390D0 (no) | 1999-12-22 |
| EP0995744A4 (en) | 2001-02-07 |
| KR20010014209A (ko) | 2001-02-26 |
| WO1998058923A1 (fr) | 1998-12-30 |
| DE69811367T2 (de) | 2003-11-27 |
| MY132897A (en) | 2007-10-31 |
| EP0995744B1 (en) | 2003-02-12 |
| US6656952B2 (en) | 2003-12-02 |
| TW382625B (en) | 2000-02-21 |
| AU8038798A (en) | 1999-01-04 |
| EP0995744A1 (en) | 2000-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301607A2 (hu) | Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0401293A2 (hu) | Új dihidropteridinonok, eljárás előállításukra és alkalmazásuk gyógyszerként | |
| HRP20080113T3 (en) | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | |
| HUP0104188A2 (hu) | Antranilsav- és tioantranilsav-N-aril-amidok, előállításuk és alkalmazásuk VEGF receptor tirozinkináz inhibítorokként | |
| HUP0204587A2 (en) | 6-position substituted indoline, production and use thereof as a medicament | |
| HUP0402313A2 (hu) | Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| HRP20000854B1 (en) | Therapeutic biaryl derivatives | |
| AR043658A1 (es) | Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona | |
| SE7714607L (sv) | 1,4-dihydropyridin-derivat, substituerade i 2-stellning, forfarande for framstellning derav samt anvendning derav som lekemedel | |
| CO5540307A2 (es) | Derivados de piperidina utiles como moduladores de la activi dad del receptor de quimoquina | |
| ES2081136T3 (es) | 3-ureido-benzodiazepinonas utiles como antagonistas de cck o de gastrina. | |
| AR017250A1 (es) | Compuestos derivados cis-substituidos de fluorometilpirrolidina, sus sales o hidratos, utiles como agentes antibacterianos, medicamento, agenteantibacteriano, y compuestos intermediarios. | |
| DE60024471D1 (de) | Benzopyran derivate | |
| AR053082A1 (es) | DERIVADOS 8-PERFLUOROALQUIL-6,7,8,9-TETRAHIDROPIRIMIDO[1,2-A]PIRIMIDIN-4-ONA SUBSTITUIDOS NHIBIDORES DE GSK3BETA Y SU EMPLEO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS. | |
| CY1110502T1 (el) | Αντιμυκητικες 4-υποκατεστημενες 5,6-διϋδρο-4η-πυρρολο[1,2-α][1,4]βενζοδιαζεπινες | |
| MY141579A (en) | Pyrrolidine-2-one derivatives, processes for their preparation, composition containing them and their use as factor xa inhibitors | |
| YU48137B (sh) | Antipikorna virusni piridazinamini i postupak za njihovo dobijanje | |
| HUP0401107A2 (hu) | Benzolgyűrűvel kondenzált új heterociklusos vegyületek és felhasználásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| ES2089041T5 (es) | Compuestos de piridinasulfonamida sustituida, composiciones herbicidas que los contienen, y procedimiento para su preparacion. | |
| MY136916A (en) | Antibacterial dehaloganated quinolone compounds | |
| RS51495B (sr) | Indolizini kao inhibitori protein kinaza | |
| CA2014521A1 (en) | 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them | |
| ATE172454T1 (de) | Pyridazinon derivate mit pharmazeutischer wirkung | |
| AR026936A1 (es) | Compuestos heterociclicos y composiciones que los contienen | |
| DE69736233D1 (de) | Pyridobenzoxazinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |